Tenax Therapeutics (TENX) Posts Q2 Loss of 14c/Share

Tenax Therapeutics (NASDAQ: TENX) reported Q2 EPS of ($0.14), $0.04 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Tenax Therapeutics (TENX) click here.

You May Also Be Interested In

• Abbott (ABT) Tops Q2 EPS by 3c; offers guidance
• Electrovaya Inc. (ELVA) PT Raised to $22 at Raymond James
• TRWD adds programmer Jeremy Woertink to its advisory board